161 related articles for article (PubMed ID: 3996945)
1. A critical approach to therapeutic apheresis in the management of inflammatory dysimmune polyneuropathies.
Valbonesi M; Montani F; Mosconi L; Zerbi D; Beltramelli A; Florio G
Haematologia (Budap); 1985; 18(1):33-43. PubMed ID: 3996945
[TBL] [Abstract][Full Text] [Related]
2. Long-term plasmapheresis therapy is effective and safe in children with chronic relapsing dysimmune polyneuropathy.
Beydoun SR; Engel WK; Karofsky P; Schwartz MU
Rev Neurol (Paris); 1990; 146(2):123-7. PubMed ID: 2157270
[TBL] [Abstract][Full Text] [Related]
3. Plasmapheresis for neurological disorders.
Schröder A; Linker RA; Gold R
Expert Rev Neurother; 2009 Sep; 9(9):1331-9. PubMed ID: 19769448
[TBL] [Abstract][Full Text] [Related]
4. Assessment of plasmapheresis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Neurology; 1996 Sep; 47(3):840-3. PubMed ID: 8797493
[TBL] [Abstract][Full Text] [Related]
5. [Results of treatment with plasmapheresis in myasthenic crisis and severe polyneuropathy].
Usnarska-Zubkiewicz L; Bilińska M; Gruszka E
Pol Arch Med Wewn; 1991 Dec; 86(6):416-9. PubMed ID: 1819792
[TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis and cytotoxic drugs for mixed cryoglobulinemia.
Valbonesi M; Montani F; Mosconi L; Florio G; Vecchi C
Haematologia (Budap); 1984; 17(3):341-51. PubMed ID: 6534839
[TBL] [Abstract][Full Text] [Related]
7. [Axonal involvement in dysimmune neuropathies].
Vallat JM
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S5-11. PubMed ID: 18087224
[TBL] [Abstract][Full Text] [Related]
8. The role of therapeutic apheresis in acute, relapsing, and chronic inflammatory demyelinating polyneuropathy.
Tindall RS
Prog Clin Biol Res; 1982; 106():205-17. PubMed ID: 6757941
[No Abstract] [Full Text] [Related]
9. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Pascual-Pascual SI
Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
[TBL] [Abstract][Full Text] [Related]
10. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum levels of endothelial leukocyte adhesion molecules in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Oka N; Akiguchi I; Kawasaki T; Ohnishi K; Kimura J
Ann Neurol; 1994 May; 35(5):621-4. PubMed ID: 7513983
[TBL] [Abstract][Full Text] [Related]
12. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
13. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
Odaka M; Yuki N; Hirata K
J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
[TBL] [Abstract][Full Text] [Related]
14. Plasmapheresis in immunologically mediated polyneuropathies.
Kiprov DD; Hofmann JC
Ther Apher Dial; 2003 Apr; 7(2):189-96. PubMed ID: 12918942
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy of chronic inflammatory demyelinating polyneuropathy].
Lünemann JD; Prass K; Zschenderlein R
Fortschr Neurol Psychiatr; 2004 Dec; 72(12):672-8. PubMed ID: 15580532
[TBL] [Abstract][Full Text] [Related]
16. [Dysimmune neuropathies: current diagnosis and therapy].
Léger JM; Larue S; Dashi F
Rev Prat; 2008 Nov; 58(17):1887-9, 1892-4. PubMed ID: 19157204
[TBL] [Abstract][Full Text] [Related]
17. Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy.
Schneider KM
Kidney Int Suppl; 1998 Feb; 64():S61-5. PubMed ID: 9475492
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of chronic immune-mediated polyneuropathies. State of the art and perspectives].
Léger JM; Chassande B
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S19-23. PubMed ID: 10896984
[TBL] [Abstract][Full Text] [Related]
19. Neurologic complications of critical illness: part II. Polyneuropathies and myopathies.
Sanap MN; Worthley LI
Crit Care Resusc; 2002 Jun; 4(2):133-40. PubMed ID: 16573417
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
